Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Arthritis, Rheumatoid × Adrenal Cortex Hormones × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 7 Prostatic Neoplasms 5 Brain Neoplasms 4 Radiation Injuries 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Hemangioma 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Urogenital Neoplasms 1 Respiratory Distress Syndrome 1 Radiation Pneumonitis 1 Popliteal Cyst 1 Polycystic Ovary Syndrome 1 Pneumonia, Viral 1 Pneumonia 1 Optic Neuritis 1 Neoplastic Cells, Circulating 1 Neoplasms, Fibrous Tissue 1 Neoplasms, Connective and Soft Tissue 1 Neoplasms, Connective Tissue 1 Neoplasms by Histologic Type 1 Neoplasm, Residual 1 Nasopharyngeal Carcinoma 1 Myelitis, Transverse 1 Myelitis 1 Myasthenia Gravis 1 Musculoskeletal Diseases 1

Interventions

Etanercept 16 Adalimumab 16 Methotrexate 10 Infliximab 8 tocilizumab 7 golimumab 6 Rituximab 6 tofacitinib 5 Abatacept 5 Tumor Necrosis Factor Inhibitors 4 Certolizumab Pegol 4 olokizumab 3 Saline Solution 2 RC-18 2 Nivolumab 2 Leflunomide 2 Antirheumatic Agents 2 veltuzumab 1 upadacitinib 1 secukinumab 1 sarilumab 1 mavrilimumab 1 entecavir 1 baricitinib 1 andecaliximab 1 Vitamin D 1 Vaccines 1 Syringes 1 Surveys and Questionnaires 1 Sulfasalazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02046603 2018-12-07

ACT-MOVE

Hoffmann-La Roche

Phase 3 Completed

162 enrolled 30 charts

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡